
Sign up to save your podcasts
Or


Attorneys Brady Bizarro and Andrew Silverio discuss today’s senate committee hearing on GLP-1 drug pricing and strategies that self-funded employers are using to manage the extreme costs of these drugs while we wait and hope for congressional action.
By The Phia Group4.9
1717 ratings
Attorneys Brady Bizarro and Andrew Silverio discuss today’s senate committee hearing on GLP-1 drug pricing and strategies that self-funded employers are using to manage the extreme costs of these drugs while we wait and hope for congressional action.

78,508 Listeners

32,081 Listeners

227,737 Listeners

63,475 Listeners

2,248 Listeners

583 Listeners

240 Listeners

111,913 Listeners

29 Listeners

1,436 Listeners

10,197 Listeners

15,801 Listeners

36 Listeners

19,284 Listeners

16,027 Listeners